Annalisa Lonetti

Bologna, 40138, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Newborn Screening for Metachromatic Leukodystrophy in Tuscany: The Paradigm of a Successful Preventive Medicine Program.

Newborn Screening for Metachromatic Leukodystrophy in Tuscany: The Paradigm of a Successful Preventive Medicine Program.

Journal: International journal of neonatal screening

Published: March 11, 2025

Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors.

Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors.

Journal: Frontiers in oncology

Published: March 21, 2022

The Glucocorticoid Receptor Polymorphism Landscape in Patients With Diamond Blackfan Anemia Reveals an Association Between Two Clinically Relevant Single Nucleotide Polymorphisms and Time to Diagnosis.

The Glucocorticoid Receptor Polymorphism Landscape in Patients With Diamond Blackfan Anemia Reveals an Association Between Two Clinically Relevant Single Nucleotide Polymorphisms and Time to Diagnosis.

Journal: Frontiers in physiology

Published: July 21, 2021

hGATA1 Under the Control of a μLCR/β-Globin Promoter Rescues the Erythroid but Not the Megakaryocytic Phenotype Induced by the Gata1 low Mutation in Mice.

hGATA1 Under the Control of a μLCR/β-Globin Promoter Rescues the Erythroid but Not the Megakaryocytic Phenotype Induced by the Gata1 low Mutation in Mice.

Journal: Frontiers in genetics

Published: June 04, 2021

Exploiting Clonal Evolution to Improve the Diagnosis and Treatment Efficacy Prediction in Pediatric AML.

Exploiting Clonal Evolution to Improve the Diagnosis and Treatment Efficacy Prediction in Pediatric AML.

Journal: Cancers

Published: March 17, 2021

B-ALL Complexity: Is Targeted Therapy Still A Valuable Approach for Pediatric Patients?

B-ALL Complexity: Is Targeted Therapy Still A Valuable Approach for Pediatric Patients?

Journal: Cancers

Published: October 16, 2020

Uncommon cytogenetic abnormalities identifying high-risk acute myeloid leukemia in children.

Uncommon cytogenetic abnormalities identifying high-risk acute myeloid leukemia in children.

Journal: Future oncology (London, England)

Published: August 20, 2020

Insights on the Interplay between Cells Metabolism and Signaling: A Therapeutic Perspective in Pediatric Acute Leukemias.

Insights on the Interplay between Cells Metabolism and Signaling: A Therapeutic Perspective in Pediatric Acute Leukemias.

Journal: International journal of molecular sciences

Published: July 23, 2020

Inhibition of Methyltransferase DOT1L Sensitizes to Sorafenib Treatment AML Cells Irrespective of MLL-Rearrangements: A Novel Therapeutic Strategy for Pediatric AML.

Inhibition of Methyltransferase DOT1L Sensitizes to Sorafenib Treatment AML Cells Irrespective of MLL-Rearrangements: A Novel Therapeutic Strategy for Pediatric AML.

Journal: Cancers

Published: June 07, 2020

Successes and Challenges for Diagnosis and Therapy of Acute Leukemia.

Successes and Challenges for Diagnosis and Therapy of Acute Leukemia.

Journal: Journal of oncology

Published: November 05, 2019

New advances in targeting aberrant signaling pathways in T-cell acute lymphoblastic leukemia.

New advances in targeting aberrant signaling pathways in T-cell acute lymphoblastic leukemia.

Journal: Advances in biological regulation

Published: August 06, 2019

Targeted Therapies for Pediatric AML: Gaps and Perspective.

Targeted Therapies for Pediatric AML: Gaps and Perspective.

Journal: Frontiers in pediatrics

Published: July 18, 2019

Showing 1-12 of 43

Last Updated: 09/26/2026